Abbott Alinity c Hemoglobin Reagent Kit may produce falsely elevated test results
Abbott Laboratories is recalling the Alinity c Hemoglobin Reagent Kit because the ARCHITECT and Alinity c assays can generate falsely elevated Hemoglobin A1c results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II medical device recall without reported illnesses, injuries, or hospitalizations. The hazard is a potential for falsely elevated test results, which presents a risk of incorrect clinical decisions. Per the rubric, this qualifies as a risk-of-harm scenario without reported injury, scoring at 3 (High).
Plain-English summary
Abbott Laboratories is recalling approximately 7,391 units of the Alinity c Hemoglobin Reagent Kit (REF: 08P4320). The affected product has been distributed throughout the United States and internationally to over 100 countries.
The ARCHITECT and Alinity c Hemoglobin A1c assays are capable of generating falsely elevated hemoglobin A1c test results when using affected reagent lots. Falsely elevated results may lead to incorrect clinical decisions regarding patient diagnosis and treatment.
The affected product is identified by UDI/DI 00380740135591 and the following lot numbers: 59561UQ04, 59779UQ05, 60229UQ07, 60540UQ09, 61011UQ10, 61349UQ01, and 61658UQ01.
The recalled product
- Product
- REF: 08P4320, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mL
- Manufacturer
- Abbott Laboratories
- Hazard
- Affected units
- 7,391
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- UDI/DI: 00380740135591/ Lots: 59561UQ04
- 59779UQ05
- 60229UQ07
- 60540UQ09
- 61011UQ10
- 61349UQ01
- 61658UQ01
Distribution
Part of a larger recall action
This product is one of 3 recalled by Abbott Laboratories under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Abbott Laboratories
See all →- HighChemistry analyzer control modules recalled over software that may give erroneous results
FDA (Devices) · 2025-12-24
- HighHematology analyzers recalled because saturation flags may not be applied
FDA (Devices) · 2025-11-19
- HighCELL-DYN Ruby hematology analyzer system expiration date validation
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby Hematology Analyzer Expiration Date Software Defect
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby hematology analyzer expiration date software defect
FDA (Devices) · 2025-04-30
Same hazard · falsely elevated results
See all →- HighEstrone RIA kits give falsely increased results from a bovine albumin lot
FDA (Devices) · 2025-07-30
- HighMedical Diagnostic Test Kit Issues Falsely Elevated Estradiol Results
FDA (Devices) · 2022-05-11
- HighEstradiol diagnostic test kits recalled for falsely elevated results
FDA (Devices) · 2022-05-11